
CoreFX expands CoreNhanced technology targeting stability, taste, and bioavailability across formats
Key Takeaways
- CoreNhanced BioTransport targets persistent nutraceutical formulation pain points by protecting labile bioactives, improving dispersion and taste, and optimizing bioavailability through controlled-release delivery.
- Pipeline actives include OmegaFX powders, berberine, CoQ10, vitamin C, and creatine, engineered for high-difficulty formats including beverages, gummies, chews, functional foods, and powders.
The company is developing solutions for omega powders, berberine, CoQ10, vitamin C, and creatine powders, while also expanding R&D capabilities.
CoreFX Ingredients LLC is advancing its CoreNhanced BioTransport technology platform as part of a broader effort to improve stability, dispersion, taste, and bioavailability across nutraceutical formulations.1
The company will be present at Natural Products Expo West, taking place March 3–6, 2026 in Anaheim, California, to discuss with brand partners the new innovations designed to address persistent formulation challenges and support scalable product development.
New solutions for formulations
CoreNhanced BioTransport is positioned as a performance-driven system that enables brands to formulate with increased efficacy, stability, and consumer experience in a wide range of delivery formats. CoreFX is currently developing solutions for several high-interest nutraceutical actives, including advanced omega powders (OmegaFX), berberine, CoQ10, vitamin C, and creatine powders. These ingredients are being tailored for challenging applications such as beverages, gummies, chews, powders, and functional foods, where maintaining stability, ensuring proper dispersion, and achieving acceptable taste profiles remain ongoing industry obstacles.
According to Denis Neville, CEO of CoreFX, CoreNhanced BioTransport is supporting the expansion of format innovations and solutions. “Format innovation is accelerating across our industry, and it is exciting to help brands deliver high-dose, multi-functional, consumer-friendly,” stated Neville, in the press release. “CoreNhanced BioTransport was built to address these formulation challenges by protecting sensitive nutrients/bioactives to enable great taste and functionality while optimizing bioavailability via controlled release.”
Capabilities of the technology
CoreFX showcased the CoreNHanced platform in 2024 at SupplySide West,
A powdered liposomal technology had also been developed to increase the bioavailability of ingredients. “One of the reasons why we believe powdered liposomes are the way to go is the versatility of the application,” stated Ben Yeap, director of innovation and science. “You can put it in a capsule, combining it with other actives to deliver a holistic functional supplement, or you can put it in a stick pack as well to offer very similar enjoyment like we would with the omega [ingredients].” CoreFX had also stated plans to continue research into this developing technology.
A focus on research
Research, development, and pilot-scale work supporting the platform are centered at the CoreFX Innovation Center in Big Bend, Wisconsin. The facility supports application testing and collaborative formulation with brand partners addressing custom development challenges. Alongside the research being done in the US, CoreFX is expanding its operational footprint internationally through the launch of CoreFX Europe, including plans for an Irish hub intended to advance R&D capabilities and increase engagement with European customers. The company describes these investments as part of a long-term strategy focused on infrastructure, partnerships, and science-driven innovation to support global nutrition brands.
Supporting nutritional solutions worldwide
CoreFX positions itself as a supplier of dry nutritional powders built on science-based technologies and a customer-first approach, with an emphasis on taste, well-being, and tailored formulation solutions. The company’s broader vision centers on leveraging its BioTransport technologies and sustainability practices to deliver scalable health and wellness solutions for the global nutraceutical market.
This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.
References
- CoreFX. CoreFX Advances CoreNhanced™ BioTransport™ Platform to Enhance Stability, Dispersion, and Taste Across Nutraceutical Applications. January 30, 2026.
- Krawiec, S. CoreFX showcases optimized nutrient delivery platform at SupplySide West 2024. November 14, 2024.
https://www.nutritionaloutlook.com/view/corefx-showcases-optimized-nutrient-delivery-platform-at-supplyside-west-2024 (Accessed 2026-02-09).





